Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F FROMM

Showing results (201-210 of 233) with videos related to

Pageof 24
Sort By:
Investigative Ophthalmology & Visual Science|December 19, 2009
The prostaglandin transporter OATP2A1 is expressed in human ocular tissues and transports the antiglaucoma prostanoid latanoprostMichaela E Kraft, Hartmut Glaeser, Kathrin Mandery, et al.
Journal of Medicinal Chemistry|March 24, 2020
Regiospecific Introduction of Halogens on the 2-Aminobiphenyl Subunit Leading to Highly Potent and Selective M3 Muscarinic Acetylcholine Receptor Antagonists and Weak Inverse AgonistsOliver Fischer, Josefa Hofmann, Hannelore Rampp, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2009
Influence of cyclooxygenase inhibitors on the function of the prostaglandin transporter organic anion-transporting polypeptide 2A1 expressed in human gastroduodenal mucosaKathrin Mandery, Krystyna Bujok, Ingrid Schmidt, et al.
EJNMMI Research|September 4, 2024
Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated <sup>18</sup>F-fluorination of boroxines, in vitro and initial in vivo evaluationKim-Viktoria Bolik, Jan Hellmann, Simone Maschauer, et al.
European Journal of Clinical Pharmacology|December 18, 2007
The association of ABCB1 polymorphisms and elevated serum digitoxin concentrations in geriatric patientsCharalampos Dragonas, Jan T Wagner, Hans J Heppner, et al.
British Journal of Clinical Pharmacology|November 8, 2024
Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in "Summaries of Product Characteristics"Wahram Andrikyan, Michael I Sponfeldner, Lea Jung-Poppe, et al.
Scientific Reports|December 5, 2025
Metabolomic and immunophenotypic signatures in cerebral amyloid angiopathy: a pilot studyThanos Tsaktanis, Arne Gessner, Steffen Pfeuffer, et al.
Cancers|December 24, 2021
An Easily Expandable Multi-Drug LC-MS Assay for the Simultaneous Quantification of 57 Oral Antitumor Drugs in Human PlasmaNiklas Kehl, Katja Schlichtig, Pauline Dürr, et al.
Journal of the American College of Cardiology|May 17, 2008
Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stentsDietmar Trenk, Willibald Hochholzer, Martin F Fromm, et al.
Pharmacogenetics|July 1, 2004
High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)Mikko Niemi, Elke Schaeffeler, Thomas Lang, et al.
Pageof 24

Showing results (201-210 of 233) with videos related to

Sort By:
Pageof 24
Investigative Ophthalmology & Visual Science|December 19, 2009
The prostaglandin transporter OATP2A1 is expressed in human ocular tissues and transports the antiglaucoma prostanoid latanoprostMichaela E Kraft, Hartmut Glaeser, Kathrin Mandery, et al.
Journal of Medicinal Chemistry|March 24, 2020
Regiospecific Introduction of Halogens on the 2-Aminobiphenyl Subunit Leading to Highly Potent and Selective M3 Muscarinic Acetylcholine Receptor Antagonists and Weak Inverse AgonistsOliver Fischer, Josefa Hofmann, Hannelore Rampp, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2009
Influence of cyclooxygenase inhibitors on the function of the prostaglandin transporter organic anion-transporting polypeptide 2A1 expressed in human gastroduodenal mucosaKathrin Mandery, Krystyna Bujok, Ingrid Schmidt, et al.
EJNMMI Research|September 4, 2024
Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated <sup>18</sup>F-fluorination of boroxines, in vitro and initial in vivo evaluationKim-Viktoria Bolik, Jan Hellmann, Simone Maschauer, et al.
European Journal of Clinical Pharmacology|December 18, 2007
The association of ABCB1 polymorphisms and elevated serum digitoxin concentrations in geriatric patientsCharalampos Dragonas, Jan T Wagner, Hans J Heppner, et al.
British Journal of Clinical Pharmacology|November 8, 2024
Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in "Summaries of Product Characteristics"Wahram Andrikyan, Michael I Sponfeldner, Lea Jung-Poppe, et al.
Scientific Reports|December 5, 2025
Metabolomic and immunophenotypic signatures in cerebral amyloid angiopathy: a pilot studyThanos Tsaktanis, Arne Gessner, Steffen Pfeuffer, et al.
Cancers|December 24, 2021
An Easily Expandable Multi-Drug LC-MS Assay for the Simultaneous Quantification of 57 Oral Antitumor Drugs in Human PlasmaNiklas Kehl, Katja Schlichtig, Pauline Dürr, et al.
Journal of the American College of Cardiology|May 17, 2008
Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stentsDietmar Trenk, Willibald Hochholzer, Martin F Fromm, et al.
Pharmacogenetics|July 1, 2004
High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)Mikko Niemi, Elke Schaeffeler, Thomas Lang, et al.
Pageof 24